This poster examines how incorporating an ACP in a NY HSB MS center improves PA processing time and approval rates, enhancing patient care and clinic satisfaction. Also, expanding ACP services involves onsite initiatives, improved documentation visibility, and educational presentations.

This poster examines how the HSSP care model’s impact on HIV, cardiovascular, MS, inflammatory, and transplant patients, showing reduced pharmacy expenses with a slight non-significant increase in total medical expenses.

STOUGHTON, Mass. & BILLINGS, Mont.–(BUSINESS WIRE)–Shields Health Solutions (ShieldsRx), the premier specialty pharmacy accelerator in the country, announced today that Billings Clinic has expanded its partnership with Shields. The partnership will build on a strong relationship with the largest independent health system

This poster examines a diabetes care model led by a pharmacy liaison, demonstrating its benefits: improved medication adherence, lower HbA1c levels, faster therapy initiation, and reduced copays. The findings suggest cost implications and potential applicability in other health systems to

This poster examines the CoP program that enhances employees’ disease state knowledge, improves patient outcomes, and fosters professional development through networking and continuous education across various roles and health system partners.

This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and economic benefits across patient populations. The impact of social determinants

This poster examines how adding an ambulatory clinical pharmacist to a rheumatology practice improves provider satisfaction, enhances patient care through timely medication approvals, and may positively impact treatment initiation and disease outcomes.

This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.  

Shields explores the impact of the cost of oral oncology medications on clinical and economic outcomes in patients with cancer managed by HSSP clinical programs.

This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited distribution drug (LDD) access, high copays, and adherence challenges.